Does REBOXETINE Cause Off label use? 20 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Off label use have been filed in association with REBOXETINE. This represents 10.8% of all adverse event reports for REBOXETINE.
20
Reports of Off label use with REBOXETINE
10.8%
of all REBOXETINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Off label use From REBOXETINE?
Of the 20 reports, 1 (5.0%) required hospitalization, and 2 (10.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REBOXETINE. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does REBOXETINE Cause?
Hyperhidrosis (21)
Weight increased (18)
Tachycardia (17)
Confusional state (16)
Intentional overdose (16)
Nausea (16)
Drug ineffective (15)
Drug interaction (15)
Sleep disorder (15)
Alanine aminotransferase increased (14)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which REBOXETINE Alternatives Have Lower Off label use Risk?
REBOXETINE vs RECLAST
REBOXETINE vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
REBOXETINE vs REGADENOSON
REBOXETINE vs REGORAFENIB
REBOXETINE vs REGORAFENIB\REGORAFENIB